ZTS
Zoetis Inc.
NYSE · USD · Stock
$79.72
+9.42 (+13.40%)
past month
Closed- Market cap
- $32.94B
- P/E
- 13.11
- Yield
- 2.66%
- Volume
- 4.1M
- 52 weeks
- $68.77 – $145
- Dividend
About
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally.
Zoetis Inc. (ZTS) is a healthcare company listed on NYSE, traded in USD. Over the past year it moved between $68.77 and $144.83, and it pays a dividend every quarter.
- Healthcare
- Drug Manufacturers - Specialty & Generic
- Parsippany, United States
- 14.5K employees
- Led by Kristin C. Peck
Coming up
Earnings
Next report
Expected EPS $1.51 · revenue $2.3B
Dividend paid
To owners on the ex-dividend day
Financials
Revenue, last 12 months
$9.53B-0.20%
Earnings
Beat the estimate
3 of 4 quarters
Q3 2025
+4.83%
Q4 2025
+5.48%
Q1 2026
-5.28%
Q2 2026
+0.95%
Earnings per share, last 12 months $6.08
Analysts
13 analysts say
Hold
12-month target$88.38+10.87%
Dividends
Yield · per share, yearly
2.66%$2.12
Ownership
- Institutions
- 100.29%
- Insiders
- 0.16%
Latest insider trade Aug 7, 2026, D AMELIO FRANK A
Prices from Yahoo Finance, may be delayed